Dey will pay
Executive Summary
Dey settles Medicaid fraud claims with U.S. and Texas and agrees to pay $18.5 mil. over charges of submitting false pricing information. Cases against Schering-Plough subsidiary Warrick and Boehringer Ingelheim subsidiary Roxane are scheduled to go to trial in August. The suits were based on information from a whistleblower (1"The Pink Sheet" Sept. 11, 2000, p. 10)...
You may also be interested in...
Dey settles with Connecticut
Dey settles Medicaid fraud claims with Connecticut and agrees to pay $900,000 over allegations of submitting false pricing information. The Napa, Calif.-based company also agrees to donate $800,000 worth of pharmaceuticals to Connecticut community health centers and clinics. Dey reached a settlement with Texas regarding a similar allegation in 2003 (1"The Pink Sheet" June 16, 2003, In Brief)...
Warrick Albuterol Medicaid "Overpayments" Total $14.6 Mil. -Texas Argues
Warrick Pharmaceuticals is responsible for $14.6 mil. in albuterol reimbursement overpayments made by the Texas Medicaid Program, Texas Attorney General John Cornyn argued in a lawsuit filed Sept. 7 in Travis County, Texas state court.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.